Elisabeth M. Hesse

ORCID: 0000-0002-6817-9153
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • COVID-19 epidemiological studies
  • COVID-19 and Mental Health
  • Intramuscular injections and effects
  • COVID-19 and healthcare impacts
  • Viral Infections and Outbreaks Research
  • Bacillus and Francisella bacterial research
  • SARS-CoV-2 and COVID-19 Research
  • Infection Control and Ventilation
  • Pharmaceutical studies and practices
  • Influenza Virus Research Studies
  • Poisoning and overdose treatments
  • Pharmacovigilance and Adverse Drug Reactions
  • COVID-19 Clinical Research Studies
  • Travel-related health issues
  • Poxvirus research and outbreaks
  • Global Health and Surgery
  • SARS-CoV-2 detection and testing
  • Heparin-Induced Thrombocytopenia and Thrombosis
  • Healthcare cost, quality, practices
  • Suicide and Self-Harm Studies
  • Frailty in Older Adults
  • Mycobacterium research and diagnosis
  • Microbial Inactivation Methods
  • Bacterial Identification and Susceptibility Testing
  • Traffic and Road Safety

Centers for Disease Control and Prevention
2019-2024

AID Atlanta
2023

National Center for Emerging and Zoonotic Infectious Diseases
2019-2023

United States Department of Health and Human Services
2023

Epidemic Intelligence Service
2019-2021

Action Network
2021

Hiram College
2017

Walter Reed Army Institute of Research
2011-2017

Medizinische Hochschule Hannover
2008

Emory University
2004

In December 2019, a cluster of cases pneumonia emerged in Wuhan City central China's Hubei Province. Genetic sequencing isolates obtained from patients with identified novel coronavirus (2019-nCoV) as the etiology (1). As February 4, 2020, approximately 20,000 confirmed had been China and an additional 159 23 other countries, including 11 United States (2,3). On January 17, CDC U.S. Department Homeland Security's Customs Border Protection began health screenings at airports to identify ill...

10.15585/mmwr.mm6906e1 article EN MMWR Morbidity and Mortality Weekly Report 2020-02-07

Nursing homes are high-risk settings for outbreaks of SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19) (1,2). During COVID-19 pandemic, U.S. health departments worked to improve infection prevention and control (IPC) practices in nursing prevent limit spread affected facilities; however, limited resources have hampered departments' ability rapidly provide IPC support all within their jurisdictions. Since 2008, Centers Medicare & Medicaid Services (CMS) has published...

10.15585/mmwr.mm6937a5 article EN MMWR Morbidity and Mortality Weekly Report 2020-09-17

This report updates previous CDC guidelines and recommendations on preferred prevention treatment regimens regarding naturally occurring anthrax.Also provided are a wide range of alternative to first-line antimicrobial drugs for use if patients have contraindications or intolerances after wide-area aerosol release Bacillus anthracis spores resources become limited multidrug-resistant B. strain is used (Hendricks KA, Wright ME, Shadomy SV, et al.;

10.15585/mmwr.rr7206a1 article EN MMWR Recommendations and Reports 2023-11-14

Recombinant zoster vaccine (RZV; Shingrix), an adjuvanted glycoprotein vaccine, was licensed by the Food and Drug Administration (FDA) recommended Advisory Committee on Immunization Practices for adults aged ≥50 years in October 2017 (1).The previously liveattenuated (ZVL; Zostavax) is ≥60 years.RZV administered intramuscularly as a 2-dose series, with interval of 2-6 months between doses.In prelicensure clinical trials, 85% 6,773 vaccinated study participants reported local or systemic...

10.15585/mmwr.mm6804a4 article EN MMWR Morbidity and Mortality Weekly Report 2019-01-31

The high mortality of systemic anthrax is likely a consequence the severe central nervous system inflammation that occurs in meningitis. Effective treatment such infections requires, at minimum, adequate cerebrospinal fluid (CSF) antimicrobial concentrations.

10.1093/cid/ciae093 article EN public-domain Clinical Infectious Diseases 2024-02-27

Subdeltoid bursitis has been reported as an adverse event after intramuscular vaccination in the deltoid muscle. Most published case reports involved influenza vaccine.

10.7326/m19-3176 article EN Annals of Internal Medicine 2020-06-22

We investigated patients with potential severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection in the United States during May-July 2020.We conducted case finding for SARS-CoV-2 through Emerging Infections Network. Cases reported were screened laboratory and clinical findings of followed by requests medical records specimens. Available abstracted to characterize patient demographics, comorbidities, course, test results. Submitted specimens underwent further testing,...

10.1093/cid/ciab148 article EN other-oa Clinical Infectious Diseases 2021-02-12

Objectives Emergency department (ED) health care personnel (HCP) are at risk of exposure to SARS-CoV-2. The objective this study was determine the attributable SARS-CoV-2 infection from providing ED care, describe personal protective equipment use, and identify modifiable factors. We hypothesized that patient increases probability acquiring infection. Methods conducted a multicenter prospective cohort 1,673 physicians, advanced practice providers (APPs), nurses, nonclinical staff 20 U.S....

10.1371/journal.pone.0271597 article EN public-domain PLoS ONE 2022-07-22

AbstractDengue virus infections have adversely impacted U.S. military operations since the Spanish-American War. The erosion of mission capabilities and lost duty days are underestimated. Appreciating incidence prevalence dengue in personnel is important to inform disease prevention strategies. Banked pre- post-deployment serum samples from 1,000 with a single deployment dengue-endemic region were tested using screening microneutralization assay detect anti-dengue-virus-neutralizing...

10.4269/ajtmh.16-0663 article EN cc-by American Journal of Tropical Medicine and Hygiene 2017-02-14

During July 11, 2018–March 29, 2019, in the United States, Vaccine Adverse Event Reporting System received 125 reports of 192 patients receiving expired inactivated influenza vaccine during 2018–19 season.

10.15585/mmwr.mm6823a3 article EN MMWR Morbidity and Mortality Weekly Report 2019-06-13

California Senate Bill 277 (SB277) eliminated non-medical immunization exemptions. Since its introduction on February 19, 2015, the rate of medical exemptions in state has increased. Filing a report to Vaccine Adverse Event Reporting System (VAERS) may be perceived as helpful applying for exemption. Our objective was describe trends reporting VAERS from coincident with SB277.This retrospective study Californian children <18 years whom submitted between June 1, 2011 and July 31, 2018. is...

10.1097/inf.0000000000002585 article EN The Pediatric Infectious Disease Journal 2020-03-16

During December 2018-February 2019, a multistate investigation identified 101 patients with vaccination-associated adverse events among an estimated 940 persons in Kentucky, Indiana, and Ohio who had received influenza; hepatitis A; pneumococcal; or tetanus toxoid, reduced diphtheria acellular pertussis (Tdap) vaccines at the workplace during September 11-November 28, 2018. These been administered by staff members of third-party health care company contracted 24 businesses. Company A...

10.15585/mmwr.mm7042a3 article EN MMWR Morbidity and Mortality Weekly Report 2021-10-21

Novice drivers are at high risk for crash involvement. We performed an analysis of causations, injury patterns and distributions novice in cars on motorcycles road traffic as a basis proper measurements.Data accident hospital records (licence < 2 years) were analysed focusing the following parameters: type, localisation mechanism, abbreviated scale (AIS), maximum AIS (MAIS), delta-v, collision speed other technical parameters compared with those experienced drivers.In 18 352 accidents area...

10.1055/s-2008-1038977 article EN Zeitschrift für Orthopädie und Unfallchirurgie 2008-12-12

The Democratic Republic of the Congo is second largest and fourth most populous country in Africa. More than two decades ongoing conflicts have degraded its healthcare system. A broad range tropical diseases, along with opportunities for collaborative medical engagements (CMEs), are prevalent. However, reports from such events this sparse. In June 2013, a CME was conducted western town Muanda. Twenty-two hours didactic sessions were collaboratively presented, 158 patients evaluated. Durable...

10.4269/ajtmh.13-0528 article EN American Journal of Tropical Medicine and Hygiene 2014-02-18

Background The Coronavirus Disease 2019 (COVID-19) pandemic, caused by Severe Acute Respiratory Syndrome 2 (SARS-CoV-2), evolved rapidly in the United States. This report describes demographic, clinical, and epidemiologic characteristics of 544 U.S. persons under investigation (PUI) for COVID-19 with complete SARS-CoV-2 testing beginning stages pandemic from January 17 through February 29, 2020. Methods In this surveillance cohort, Centers Control Prevention (CDC) provided consultation to...

10.1371/journal.pone.0249901 article EN public-domain PLoS ONE 2021-04-15
Coming Soon ...